Porcine xenografts vs. (cryopreserved) allografts in the management of partial thickness burns: is there a clinical difference?
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 24018214.
- Also identified by DOI 10.1016/j.burns.2013.08.020.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Porcine xenografts and cryopreserved allografts are used for the management of partial thickness burns and both biological materials have strong advocates with regard to clinical performance, the possibility of disease transfer from donor to recipient and other clinical aspects. A literature analysis was performed in an attempt to investigate whether true (statistically significant) differences exist on clinical performance and on other determinants for use. Comparing the results of this study with a similar, previously published study performed on possible differences amongst different types of allograft in the management of partial thickness burns, both allografts and porcine xenograft seem to perform equally well clinically with regard to healing related outcomes. In addition, the risk of disease transfer, in real life, was shown to be minimal. Consequently, clinical aspects being equal, other aspects such as price and availability should be used to decide which material to use for the management of partial thickness burns.
Medical subject headings
- Burns
- Skin Transplantation
- Transplantation, Heterologous
- Transplantation, Homologous